期刊文献+

镁补充对2型糖尿病大鼠红细胞胰岛素受体亲和力的影响 被引量:4

Influence of magnesium supplementation on insulin receptor affinity in erythrocytes of type 2 diabetes rats
原文传递
导出
摘要 目的研究镁补充对2型糖尿病大鼠红细胞胰岛素受体亲和力的影响。方法将高脂饲料喂饲加链脲佐菌素腹腔注射诱发的2型糖尿病大鼠随机分成糖尿病对照及高、中、低剂量组,饲料中分别加入氧化镁(以镁计)0、2000、1000、200mg/kg,正常对照组喂饲普通饲料,共喂养4周。检测红细胞胰岛素受体结合常数、结合容量、受体数目、空腹血糖及空腹胰岛素等指标,计算胰岛素抵抗指数与敏感指数。结果高剂量组高亲和力胰岛素受体结合常数、结合容量和受体数目分别为(1.24±0.47)×109L/mol、(1.26±0.53)×1014/L和80.23±0.47,均高于糖尿病对照组;胰岛素抵抗指数较糖尿病对照组降低而胰岛素敏感指数升高。结论镁补充能提高2型糖尿病大鼠红细胞胰岛素受体亲和力,改善胰岛素抵抗。 Objective To observe the influence of oral magnesium supplementation on insulin receptor affinity in erythrocytes of type 2 diabetes rats. Method Type 2 diabetes rats were induced by high-fat-diet and intraperitoneal injection of streptozocin, and divided into 4 groups. Magnesium was supplemented in high-fat-diet at the dose of 2000, 1000, 200 and 0 mg/kg,respectively. Normal control rats were fed with ordinary diet. Rats were killed after four weeks. Erythrocytes insulin receptor number, combination constants, combined capacity, fasting insulin level and fasting glucose levels were measured, and insulin resistance index and insulin sensitivity index were calculated. Results High affinity insulin receptor combination constant, combined capacity and receptor number in high dosage group were( 1.24 +0.47) x 109L/tool, ( 1.26 +0.53 ) x 1014/L and 80.23 + 0.47 respectively, significantly higher than diabetes control group. Insulin resistance index decreased and insulin sensitivity index increased in high dosage group than diabetes control. Conclusion Magnesium supplementation could improve erythrocyte insulin receptor affinity and improve insulin resistance in type 2 diabetic rats.
出处 《卫生研究》 CAS CSCD 北大核心 2013年第2期217-220,共4页 Journal of Hygiene Research
基金 国家自然科学基金项目(No.30901187)
关键词 2型糖尿病 胰岛素受体 胰岛素抵抗 magnesium, type 2 diabetes mellitus, insulin receptor, insulin resistance
  • 相关文献

参考文献15

二级参考文献55

共引文献365

同被引文献65

  • 1张宏馨,李军,赵燕燕,范倩倩,薛瑞.富铬酵母对糖尿病小鼠血糖和微循环的影响[J].现代预防医学,2007,34(19):3673-3674. 被引量:4
  • 2Kleefstra N, Houweling ST, Jansman FG, et al. Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese western population - A randomized, double-blind, placebo-controUed trial [J]. Diabetes Care, 2006, 29 (3): 521-525.
  • 3Dharam PC. Magnesium deficiency in type 2 diabetes [M ]//Watson RR, Preedy VR, Zibadi S. Magnesium in Human Health and Disease. Totowa: Humana Press, 2013 : 119-126.
  • 4Song Chanhee, Song IK, Ju SY, et al. Serum Magnesium level is negatively associated with fasting serum glucose level in Korean adults [J]. Biol Traee Elem Res, 2011, 143 (2) : 612-618.
  • 5DONG JY, XUN PC, HE K, et al. Magnesium intake and risk of type 2 diabetes meta-analysis of prospective cohort studies [J].Diabetes Care, 2011, 34 (9): 2116-2122.
  • 6Simmons D, Joshi S, Shaw J. Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome [ J ]. Diabetes ResClinPract, 2010, 87 (2): 261-266.
  • 7Masood N, Baloch GH, Ghori RA, et al. Serum Zinc and Magnesium in type-2 diabetic patients [J]. J Coil Physicians Surg Pak, 2009, 19 (8): 483-486.
  • 8CHEN WY, CHEN C J, LIU CH, et al. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/H1J diabetic mice [J]. Diabetes Obes Metab, 2009, 11 (4) : 293- 303.
  • 9ZHAO P, WANG JY, MA H, et al. A newly synthetic Chromium complex-chromium (D-phenylalanine) 3 activates AMP-activated protein kinase and stimulates glucose transport [J]. Bioehem Pharmaeol, 2009, 77 (6): 1002-1010.
  • 10Balk EM, Tatsioni A, Lichtenstein AH, et al. Effect of Chromium supplementation on glucose metabolism and lipids - A systematic review of randomized controlled trials[J]. Diabetes Care, 2007, 30 (8) : 2154-2163.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部